Ken Beckman, MD, FACS, is a corneal specialist and clinical assistant professor at The Ohio State University. At the 2025 ...

Damage to the cornea affects millions of people worldwide. Empa researchers are working on a transparent, biocompatible ...

In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.

The optic disc is a non-sensory spot in the retina where the axons of the ganglion cells carrying afferent light-induced impulses to the visual cortex of the brain converge to leave the eye. It ...